Importantly, unlike chemotherapy resistance, which occurs at the level of tumor cells, this process was found to be mediated through host-PAFR signaling, which manipulates the immune response via immunosuppressive regulatory T cells (Tregs) [153]. The gene discussed is PTAFR; the disease is neoplasm.